Diffusion Pharmaceuticals
is a biotechnology firm that researches oxygen therapeutics for the treatment of cancer and orphan diseases... Read moreDiffusion Pharmaceuticals
is a biotechnology firm that researches oxygen therapeutics for the treatment of cancer and orphan diseases... Read more
2001
PublicMerged with EIP Pharma Inc.NASDAQDFFN
News
Aug 16, 2023
Life Care News
Diffusion Pharmaceuticals: Diffusion Pharmaceuticals Stockholders Approve Merger with
Aug 14, 2023
MarketScreener
Diffusion Pharmaceuticals: Diffusion Pharmaceuticals : EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies - Form 8-K
Jul 23, 2023
Benzinga
Diffusion Pharmaceuticals: SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DFFN, TRTN, CNXC
Apr 05, 2023
Global Legal Chronicle
Diffusion Pharmaceuticals: Diffusion Pharmaceuticals' Merger with EIP Pharma Inc.
Apr 03, 2023
centralcharts
Press Release: Diffusion Pharmaceuticals : SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, LSI, EXR, DFFN
Apr 01, 2023
Picante Today
Diffusion Pharmaceuticals: DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN
Mar 30, 2023
GlobalNewswire
Press Release: Diffusion Pharmaceuticals : BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diffusion Pharmaceuticals Inc. (Nasdaq- DFFN), U.S. Xpress Enterprises, Inc. (NYSE - USX), TCR Therapeutics Inc. (Nasdaq - TCRR), Costar Technologies, Inc. (OTC - CSTI)
Mar 30, 2023
Citybizlist
Diffusion Pharmaceuticals: EIP Pharma and Diffusion Pharmaceuticals to Merge
Mar 24, 2023
Owler
Diffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals's employee count changed from 16 in Dec 2021 to 13 in Dec 2022
Dec 16, 2022
Markets Insider
Diffusion Pharmaceuticals: Diffusion's Shareholder LifeSci Supports Company's Strategic Review Process And Director Nominees
Diffusion Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10